Acro to provide multi-type explosive tester for commercial and military explosives, complementing its existing peroxide explosive tester.

New York, NY -– Acro, Inc., a developer of explosive detection solutions, today announced the conclusion of the negotiations of a technology agreement with LSRI – Life Science Research Israel Ltd., a subsidiary of IIBR – Israel Institute for Biological Research.

Under the terms of the agreement, LSRI will license the long-proven technology of IIBR's explosives testing kit (ETK) to Acro, for incorporation into Acro's pen-like device, allowing the detection of commercial and military explosives. The agreement is subject to minimum annual revenues to be achieved by Acro and royalties to be paid to LSRI. The technical appendix of the agreement will be signed in the next few weeks.

The new device will complement Acro's ACRO-P.E.T., the company’s peroxide explosive tester for the detection of improvised explosives.

"The agreement with LSRI will allow Acro to provide unique, reliable and easy-to-use explosive testers for the entire spectrum of military, commercial and improvised explosives, using the company's patented pen-like tool," said Acro Chairman and CEO Gadi Aner. "This is an important milestone in Acro's evolution as a company offering a full array of explosive testers providing immediate detection in the field."

IIBR's ETK is a portable micro-laboratory for rapid field detection of explosives. It is used by many security forces around the world.

ACRO-P.E.T. is designed for rapid field detection of peroxide-based explosives, such as triacetone triperoxide (TATP). Its main advantages include high sensitivity, high selectivity, fast response, simple operation, small size and cost effectiveness.

LSRI focuses on the commercialization of IIBR’s novel technologies and scientific achievements. Established in 1979, LSRI’s mandate is to promote biomedical projects and market IIBR-developed products and services. LSRI represents IIBR in the establishment of all forms of collaboration, joint ventures and partnerships with private and public companies. For more information about LSRI, visit www.iibr.gov.il/LSRI.asp

Acro, Inc. develops explosives detection technologies. The company has developed a unique patented technology for identifying peroxide-based explosives, such as TATP. Acro’s Advisory Board includes Prof. K. Barry Sharpless, winner of the 2001 Nobel Prize for Chemistry, and Prof. Richard A. Lerner, President and CEO of The Scripps Research Institute, considered one of the world’s most influential scientific institutes. For more information about Acro, visit www.acrosec.com.

Acro
27.09.2007